MARKET

HROW

HROW

Harrow Health Inc
NASDAQ
40.70
+0.26
+0.64%
After Hours: 38.16 -2.54 -6.23% 19:57 08/10 EDT
OPEN
40.47
PREV CLOSE
40.44
HIGH
41.08
LOW
39.64
VOLUME
803.91K
TURNOVER
--
52 WEEK HIGH
54.85
52 WEEK LOW
28.54
MARKET CAP
1.52B
P/E (TTM)
-99.5353
1D
5D
1M
3M
1Y
5Y
1D
Harrow (HROW) Reports Q2 Loss, Misses Revenue Estimates
NASDAQ · 3h ago
Harrow: Strong Iheezo Demand and Confident 2026 Guidance Support Buy Rating Despite Near-Term Miss
TipRanks · 5h ago
Harrow Health Sees Strong Q2 Growth, Reaffirms 2026 Outlook
TipRanks · 5h ago
Harrow Health GAAP EPS of -$0.46 misses by $0.28, revenue of $70.7M beats by $0.35M
Seeking Alpha · 7h ago
Harrow Q2 EPS $(0.46) Misses $(0.21) Estimate, Sales $70.661M Beat $70.342M Estimate
Benzinga · 7h ago
*Harrow 2Q Loss/Shr 46c >HROW
Dow Jones · 7h ago
*Harrow 2Q Rev $70.7M >HROW
Dow Jones · 7h ago
Harrow: Q2 Earnings Snapshot
Barchart · 11h ago
More
About HROW
Harrow, Inc. is a provider of ophthalmic disease management solutions. It offers a portfolio of products that address conditions affecting both the front and back of the eye, such as dry eye disease, wet age-related macular degeneration, cataracts, refractive errors, glaucoma and a range of other ocular surface conditions and retina diseases. It owns commercial rights to portfolios of branded ophthalmic pharmaceutical products in the United States, all of which are marketed under the Harrow name. It owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical-compounding business. It owns United States commercial rights to various products: IHEEZO, VEVYE, TRIESENCE, VIGAMOX, FLAREX, NATACYN, BYQLOVI and others. Its development-stage programs include MELT-300, H-N08, CR-01, and MELT-210. VIGAMOX (moxifloxacin hydrochloride ophthalmic solution) 0.5%, a fluoroquinolone antibiotic eye drops for the treatment of bacterial conjunctivitis caused by susceptible strains of organisms.

Webull offers Harrow Inc stock information, including NASDAQ: HROW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HROW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HROW stock methods without spending real money on the virtual paper trading platform.